PRO: Procalcitonin has clinical utility in children with community-acquired pneumonia
Todd A Florin1, Derek J Williams2
1Department of Pediatrics, Northwestern University Feinberg School of Medicine and Division of Pediatric Emergency Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Insights
Procalcitonin (PCT) testing can help doctors decide when to use antibiotics in children with respiratory infections. A very low PCT level suggests a low risk of bacterial infection, potentially reducing unnecessary antibiotic prescriptions.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Diagnostics
Background:
- Lower respiratory tract infections (LRTI) are common in children, frequently leading to antibiotic prescriptions.
- Viral infections often cause paediatric LRTI, yet bacterial infections are commonly suspected, leading to over-prescription of antibiotics.
- Procalcitonin (PCT) is a biomarker investigated for guiding antibiotic stewardship.
Purpose of the Study:
- To evaluate the utility of procalcitonin (PCT) in managing antibiotic use for paediatric lower respiratory tract infections (LRTI), including community-acquired pneumonia (CAP).
- To assess the negative predictive value of low PCT concentrations in identifying children with LRTI at low risk for bacterial infections.
Main Methods:
- Review of recent data on PCT concentrations in children with LRTI.
- Analysis of the negative predictive value of low PCT levels.
- Comparison of PCT utility in paediatric versus adult LRTI studies.
Main Results:
- Very low PCT concentrations demonstrate a high negative predictive value for typical bacterial infections in children with LRTI.
- PCT can aid clinicians in making informed decisions regarding antibiotic initiation or discontinuation.
- The potential benefit of PCT is particularly significant in paediatric CAP where viral causes are prevalent.
Conclusions:
- Procalcitonin is a valuable, though not perfect, diagnostic tool for antibiotic decision-making in paediatric LRTI.
- Utilizing PCT can help reduce unnecessary antibiotic exposure in children, especially in cases of community-acquired pneumonia.
- Further research supports PCT's role in optimizing antibiotic stewardship in paediatric respiratory infections.
Abstract:
Procalcitonin (PCT) is a useful, albeit imperfect, diagnostic aid that can help clinicians make more informed decisions around antibiotic use in children with lower respiratory tract infections (LRTI), including community-acquired pneumonia (CAP). Recent data suggest that a very low PCT concentration has a high negative predictive value to identify a population of children at low risk of typical bacterial infections. Although the preponderance of data on the clinical utility of PCT in LRTI come from adult studies, the potential for benefit is likely greatest in paediatric CAP and other LRTIs where viral aetiologies predominate, yet antibiotics are frequently prescribed.
More Related Videos
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Pneumonia III: Complications and Assessment
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Acute Pyelonephritis II: Diagnostic Studies and Management
